Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

p16INK4a/CDKN2A Mouse anti-Human, Clone: R15-A, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP305757200UL

 View more versions of this product

Catalog No. NB154885


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

p16INK4a/CDKN2A Monoclonal antibody specifically detects p16INK4a/CDKN2A in Human samples. It is validated for Immunohistochemistry, Immunohistochemistry (Paraffin)
Specifications

Specifications

p16INK4a/CDKN2A
Monoclonal
Unconjugated
20mM Tris-HCl (pH 8.0) and 20mg/mL BSA
Mouse
Immunogen affinity purified
RUO
Primary
Human
IgG
Immunohistochemistry, Immunohistochemistry (Paraffin)
R15-A
Immunohistochemistry, Immunohistochemistry-Paraffin 1:100
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, p16, p16-INK4, p16INK4a, p16-INK4a, P19, p19ARF, TP16
Human p16INK4a/CDKN2A protein
200 μg
ABC Transporters, Biologically Active Proteins, Cancer, Cell Cycle and Replication, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Tumor Suppressors
1029
Store at 4°C. Do not freeze.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.